注册 | 登录
点击这里给我发消息
所有产品
  • 所有产品
  • 一抗
  • 裂解液
>   首页   >   产品   >   一抗   >   其他   >   Anti-CCR8 / CD198 Reference Antibody (BMS-986340)   

Anti-CCR8 / CD198 Reference Antibody (BMS-986340)

     
  • 0 - Anti-CCR8 / CD198 Reference Antibody (BMS-986340) APR11168
    Anti-CCR8 / CD198 Reference Antibody (BMS-986340) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
  • 0 - Anti-CCR8 / CD198 Reference Antibody (BMS-986340) APR11168
    The purity of Anti-CCR8 / CD198 Reference Antibody (BMS-986340) is 100%, determined by SEC-HPLC.
  • 0 - Anti-CCR8 / CD198 Reference Antibody (BMS-986340) APR11168
    Immobilized Human CCR8-VLP at 16 µg/mL can bind BMS-986340, EC50= 10.44 µg/mL.
  • 产品详情
  • 实验流程
Product Information
Application
  • Applications Legend:
  • E=ELISA
  • WB=Western Blotting
  • IHC=Immunohistochemistry
  • IHC-P=Immunohistochemistry (Paraffin)
  • IP=Immunoprecipitation
  • IF=Immunofluorescence
  • IC=Immunochemistry
  • ICC=Immunocytochemistry
  • FC=Flow Cytometry
  • DB=Dot Blot
Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Primary Accession P51685
Reactivity Human
Clonality Monoclonal
Isotype IgG1-REMK
Calculated MW 40844 Da
Additional Information
Target/Specificity CCR8 / CD198 / CKRL1 / CMKBR8 / CMKBRL2
Expression system CHO

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.

Protein Information
Name CCR8
Synonyms CKRL1, CMKBR8, CMKBRL2
Function G protein-coupled receptor that can bind a variety of chemokines, such as CCL1, CCL8, CCL16, CCL18 (PubMed:23999500, PubMed:35041514). Regulates monocyte and eosinophil chemotaxis. Undergoes internalization upon CCL18 binding, leading to induced migration and calcium flux of highly polarized Th2 cells (PubMed:23999500). In microglial cells, promotes phagocytosis with CCL18 through NF-kappa-B and Src signaling pathways (PubMed:35041514). Stimulation of the CCL1-CCR8 signaling axis protects the gut from acute intestinal damage (By similarity).
Cellular Location Cell membrane; Multi-pass membrane protein
Tissue Location Expressed in unstimulated CD4(+) and CD8(+) T-cells and polymorphonuclear cells.
Research Areas
FeedBack

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。

如有疑问,联系:0512-88856768 tech-china@abcepta.com.


我要评价